Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) is a publicly traded Healthcare sector company. As of May 21, 2026, LIXT trades at $5.60 with a market cap of $54.60M and a P/E ratio of 0.00. LIXT moved +1.90% today. Year to date, LIXT is +48.15%; over the trailing twelve months it is +327.48%. Its 52-week range spans $0.64 to $6.26. Rallies surfaces LIXT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LIXT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LIXT recently traded at $5.60. Market cap is $54.60M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $5.60 |
| Market Cap | $54.60M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.26 |
| 52-Week Low | $0.64 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-6.01M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-6.01M | $0.00 |
| 2024 | $0 | $-3.59M | $-1.59 |
| 2023 | $0 | $-5.09M | $-2.66 |
| 2022 | $0 | $-6.31M | $-0.40 |
LIXT analyst coverage data. Average price target: $0.00.